| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/13/2004 | WO2003033657A3 Antisense antiviral agent and method for treating ssrna viral infection |
| 05/13/2004 | WO2003006652A3 Inhibition of specific histone deacetylase isoforms |
| 05/13/2004 | WO2002096195A8 Treatment or replacement therapy using transgenic stem cells delivered to the gut |
| 05/13/2004 | WO2002038171A9 METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES OF α-L-IDURONIDASE |
| 05/13/2004 | WO2002000232A9 Methods and compositions for developing spore display systems for medicinal and industrial applications |
| 05/13/2004 | US20040093627 Methods |
| 05/13/2004 | US20040093626 Screening modulators of g-protein couple receptors to identify appetite control agent for treatment of physiological eating disorders and obesity |
| 05/13/2004 | US20040093623 Non-human animal disease models |
| 05/13/2004 | US20040092911 Ophthalmic drug delivery device |
| 05/13/2004 | US20040092730 Hepatitis C virus non-structural NS3/4A fusion gene |
| 05/13/2004 | US20040092722 Preparing immunoglobulin for diagnosis and treatment of cardiovascular disorders |
| 05/13/2004 | US20040092487 Inhibitors of epoxide hydrolases for the treatment of hypertension |
| 05/13/2004 | US20040092474 Controlling cell proliferation; contacting cell with reporter molecules; measuring, calibrating activation |
| 05/13/2004 | US20040092473 Method for nucleic acid transfection of cells |
| 05/13/2004 | US20040092463 PIM-1 is a protein serine/threonine kinase predominantly expressed in hematopoietic tissues; antisense agents for PIM-1 inhibition; treating hyperproliferative diseases; kits; drug screening; diagnostic primers |
| 05/13/2004 | US20040092462 Receptors for lysophosphatidic acid (LPA), aka endothelial differentiation genes (EDG); gene expression inhibition of EDG via antisense agents; drug screening; diagnostic probes; hyperproliferative disorders |
| 05/13/2004 | US20040092461 Modulation of phosphodiesterase 1B expression |
| 05/13/2004 | US20040092450 Polypeptide that has mitogenic activity; treating fibroproliferative disorders |
| 05/13/2004 | US20040092433 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 05/13/2004 | US20040092019 Particle-mediated transformation of animal tissue cells |
| 05/13/2004 | US20040092009 Codon optimized synthetic plasmids |
| 05/13/2004 | US20040092007 Allelic growth differentiation factor-9b (GDF-9B) for treatment annd prevention of sex disorders; in vitro fertilization; artificial insemination; veterinary medicine |
| 05/13/2004 | US20040091996 Genetically engineered virus which propagates specifically in tumor cells and codes angiogensis inhibitors; antitumor/antiproliferative agents |
| 05/13/2004 | US20040091995 Replication defective poxvirus coding granulocyte-monocyte-colony stimulating factor (GM-CSF) for treatment and prevention of neutropenia and tumor disorders; antitumor/antiproliferative agents |
| 05/13/2004 | US20040091964 Modified proteins, isolated novel peptides,and uses thereof |
| 05/13/2004 | US20040091907 GEF-H1b: biomarkers, complexes assays and therapeutic uses thereof |
| 05/13/2004 | US20040091898 Polynucleotide sequence encoding phosphatidylinositol(PI3k) protein; useful in reducing cell death after trauma and overcoming insulin resistance |
| 05/13/2004 | US20040091894 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 05/13/2004 | US20040091890 Life sciences business systems and methods |
| 05/13/2004 | US20040091885 Use of consensus sequences for targeted homologous gene isolation and recombination in gene families |
| 05/13/2004 | US20040091878 Zinc finger domain recognition code and uses thereof |
| 05/13/2004 | US20040091502 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 05/13/2004 | US20040091498 Defensins: use as antiviral agents |
| 05/13/2004 | US20040091484 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/13/2004 | US20040091479 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 05/13/2004 | US20040091468 Novel transcriptional mediators of blood vessel development and endothelial differentiation |
| 05/13/2004 | US20040091464 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 05/13/2004 | US20040091456 Novel recombinant adenovirus vector with relieved side effects |
| 05/13/2004 | CA2503749A1 Method of expressing protein having unnatural amino acid integrated thereinto |
| 05/13/2004 | CA2503634A1 Alpha 1-antichymotrypsin in combination with alpha 1-antitrypsin for the treatment of wounds |
| 05/12/2004 | EP1418183A1 Cystic fibrosis gene |
| 05/12/2004 | EP1418179A2 Compositions and methods for detecting and modulating rna activity and gene expression |
| 05/12/2004 | EP1417971A2 Use of an angiogenic factor for the treatment of microvascular angiopathies |
| 05/12/2004 | EP1417351A2 Antisense modulation of apolipoprotein(a) expression |
| 05/12/2004 | EP1417350A2 Antisense modulation of hormone-sensitive lipase expression |
| 05/12/2004 | EP1417349A2 Novel molecular target for neurotoxicity |
| 05/12/2004 | EP1417342A2 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 05/12/2004 | EP1417323A2 Humanised baculovirus |
| 05/12/2004 | EP1417308A1 Human protooncogene kg-20 and protein encoded therein |
| 05/12/2004 | EP1417304A2 Method and composition for inhibiting heparanase activity |
| 05/12/2004 | EP1417233A2 Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof |
| 05/12/2004 | EP1417229A2 Methods and compounds for the targeting of protein to exosomes |
| 05/12/2004 | EP1417228A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417227A2 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417217A2 Inhibition of behab cleavage and primary central nervous system (cns) tumors |
| 05/12/2004 | EP1416986A2 Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 05/12/2004 | EP1416973A2 Modulation of mhc class i antigen presentation |
| 05/12/2004 | EP1416972A2 Chimeric molecules to modulate gene expression |
| 05/12/2004 | EP1416971A1 Gene transfer imaging and uses thereof |
| 05/12/2004 | EP1416969A2 Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier |
| 05/12/2004 | EP1416961A1 Composition and method for the treatment of disease |
| 05/12/2004 | EP1416789A1 Propagation of human hepatoblastoma cell in non-human animals |
| 05/12/2004 | EP1259537A4 Gene expression system based on chimeric receptors |
| 05/12/2004 | EP0971731B1 Suppression of malignancy utilizing ribonucleotide reductase r1 |
| 05/12/2004 | EP0969720A4 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 05/12/2004 | EP0804577B1 cDNA ENCODING A BMP TYPE II RECEPTOR |
| 05/12/2004 | EP0792156B1 Medicaments for the prevention or treatment of vascular hemorrhaging |
| 05/12/2004 | EP0781092B1 Nucleic acid encoding adenovirus e1a polypeptide for sensitizing tumor cells to chemotherapy or irradiation |
| 05/12/2004 | CN1496271A Method of treating diseases in association with decrease in expression of AOP-1 gene or AOP-1 and remedies for diseases |
| 05/12/2004 | CN1494923A Medicine capable of repairing human body gene for curing diseases and its preparation method. |
| 05/11/2004 | US6734338 Using composition for in vitro and in vivo transfection of vertebrate male germ cells comprising a nucleic acid or transgene and a gene delivery system, and optionally a protective internalizing agent |
| 05/11/2004 | US6734295 Modified CRE recombinase gene for mammals |
| 05/11/2004 | US6734285 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, inflammation, diabetic retinopathy, rheumatoid arthritis and psoriasis |
| 05/11/2004 | US6734284 Exhibits high affinity for the gfr alpha 3- ret receptor complex and unique subregions in its amino acid sequence |
| 05/11/2004 | US6734174 Modulators of the function of receptors of the TNF/NGF receptor |
| 05/11/2004 | US6734173 HSP DNA vaccines |
| 05/11/2004 | US6734172 Surface receptor antigen vaccines |
| 05/11/2004 | US6734171 Mixing aggregation-preventing agent, lipid and detergent, dialyzing in buffered salt solution |
| 05/11/2004 | US6734167 Uses of transport proteins |
| 05/11/2004 | US6734161 Peptide nucleic acids having antibacterial activity |
| 05/11/2004 | US6734160 Nucleotide sequences coding polypeptide for use in the treatment of diabetes |
| 05/11/2004 | US6734015 Capable of self-renewal and differentiation into neurons, but not into glia, i.e. astrocytes and oligodendrocytes |
| 05/11/2004 | US6734008 Liquid or frozen mixture for use in maintaince of viral particles; for use in gene therapy |
| 05/11/2004 | US6733997 Isolated nucleic acids encoding a secretory signal for expression and secretion of heterologous recombinant proteins |
| 05/11/2004 | US6733994 Highly expressible genes |
| 05/11/2004 | US6733990 Useful for the treatment of immune, hematologic, fibrotic, hepatic, and respiratory disorders such as asthma using g-protein coupled receptors (gpcr) |
| 05/11/2004 | US6733981 Antibodies to interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| 05/11/2004 | US6733777 Cationic reagents of transfection |
| 05/11/2004 | US6733776 Treating androgenic alopecia; an antisense nucleic acid molecule that hybridizes to an androgen receptor gene so as to inhibit androgen receptor expression; an expression system therefor; and an antiandrogen |
| 05/11/2004 | US6733758 Fibrinogen binding protein originating from coagulase-negative staphylococcus |
| 05/11/2004 | US6733755 Ligand for vascular endothelial growth factor receptor |
| 05/11/2004 | US6733747 Prosthetic grafts |
| 05/11/2004 | CA2074188C Vector with multiple tat activation response elements affecting gene expression |
| 05/08/2004 | CA2512484A1 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 05/06/2004 | WO2004038407A2 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12) |
| 05/06/2004 | WO2004038406A2 Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 42 (gpr42) |
| 05/06/2004 | WO2004038405A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) |
| 05/06/2004 | WO2004038021A1 Gpr54 knock-out mammals and screening methods using them |
| 05/06/2004 | WO2004038003A2 Human polypeptides encoded by polynucleotides and methods of their use |
| 05/06/2004 | WO2004037977A2 Use of chimeric nucleases to stimulate gene targeting |